Metabolism, Excretion, and Pharmacokinetics of [14C]-Radiolabeled Aleglitazar: A Phase I, Nonrandomized, Open-Label, Single-Center, Single-Dose Study in Healthy Male Volunteers

Autor:	Sturm, Stefan1 stefan.sturm@roche.com, Seiberling, Michael2, Weick, Idelette1, Paehler, Axel1, Funk, Christoph1, Ruf, Thorsten1
Zdroj:	Clinical Therapeutics. Feb2012, Vol. 34 Issue 2, p420-429. 10p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect